Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.068 | 0.6 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.7 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.041 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |